Announcement

Conquer Cancer Announces 2020 Genitourinary Cancers Symposium Merit Award Recipients

Contact
Vicki Kilpatrick
Aerial view of Golden Gate Bridge in San Francisco

Alexandria, Va. – Conquer Cancer, the ASCO Foundation is pleased to announce the recipients of the 2020 Genitourinary Cancers Symposium Merit Awards.

These awards recognize the quality and scientific merit of research submitted by oncology fellows and trainees to an ASCO-sponsored or cosponsored meeting. The selected early-career researchers of these Conquer Cancer Merit Awards are presenting their findings at the 2020 Genitourinary Cancers Symposium in San Francisco, Calif., February 13 – 15, 2020. 

2020 Recipients:

Ziad Bakouny, MD, MSc,  Dana-Farber Cancer Institute
Marco Bandini, MD, Vita-Salute San Raffaele University
Joost Marijn Blok, MD,  The Netherlands Cancer Institute
Landon Carter Brown, MD, Duke Cancer Institute
Carlo Cattrini, MD, IRCCS Ospedale Policlinico S. Martino
Timothy Nguyen Clinton, MD, MPH, Memorial Sloan-Kettering Cancer Center
Eugene Blanchard Cone, MD, Brigham and Women's Hospital, Harvard Medical School
Shruti U. Gandhy, MD, PhD, National Cancer Institute
Anis Hamid, MBBS, Dana-Farber Cancer Institute
Daniel Kwon, MD, University of California, San Francisco
Rebecca Levin-Epstein, MD, University of California, Los Angeles
Tim Nestler, MD, University Hospital of Cologne
Kenrick Ng, MA, MBBChir, MRCP, UCL Cancer Institute
Pier Vitale Nuzzo, MD, Dana-Farber Cancer Institute
Neil Rohit Parikh, MD, MBA, Baylor College of Medicine
Irbaz Bin Riaz, MBBS, MS, Mayo Clinic, Rochester
Justin Shaya, MD, University of California, San Diego 
Nirmish Singla, MD, University of Texas Southwestern Medical Center
Maarten J. van der Doelen MD, Radboud University Medical Center
Paul Vincent Viscuse, MD, Marshall University
Risa Liang Wong, BS, MD, Fred Hutchinson Cancer Research Center


The 2020 Genitourinary Cancers Symposium Merit Awards are supported by:*

Anonymous, AbbVie, Inc., ASCO Employees, Association of Northern California Oncologists, AstraZeneca, Friends and Family of Dr. and Mrs. Ronald Beller, Dr. and Mrs. Douglas W. Blayney, Breast Cancer Research Foundation®, Bristol-Myers Squibb, Jonathan K. and Cora Y. Cho Charitable Fund, Eisai Inc., Estate of Darla C. Ellis, Epiphany Partners Inc., GlaxoSmithKline Oncology, Harborside, Ipsen Biopharmaceuticals Inc., Kimberly Irvine, Michael Kelley, MD & Elise Hoffman, PharmD, William T. Leslie, MD, Lilly, Loxo Oncology Inc., a wholly owned subsidiary of Eli Lilly and Company, Gary H. Lyman, MD, MPH, FASCO and Nicole M. Kuderer, MD, Therese Marie Mulvey, MD, FASCO, Friends and Family of Dr. James B. Nachman, New Rhein Healthcare, Northern New England Clinical Oncology Society, Dr. Kathleen Pritchard Medicine Professional Corporation, Sarah Cannon Research Institute, Frances A. Shepherd, MD, FASCO, Stephen A. Sherwin, MD, Drs. Rachna and Puneet Shroff, Mr. Jackson G. Simpson, Syndax Pharmaceuticals, Inc., Nizar M. Tannir, MD, Anthony and Marilyn Tolcher, and Dr. Michael and Deborah Troner.

*As of 2/14/20